Current Treatment Options for Local Residual Nasopharyngeal Carcinoma

Local residual disease occurs in 7-13 % after primary treatment for nasopharyngeal carcinoma (NPC). To prevent tumor progression and/or distant metastasis, treatment is indicated. Biopsy is the “gold standard” for diagnosing residual disease. Because late histological regression frequently is seen a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Stoker, S. D., van Diessen, J. N. A., de Boer, J. P., Karakullukcu, B., Leemans, C. R., Tan, I. B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2013
Gaiak:
Head and Neck Cancer (JB Vermorken, Section Editor)
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3841576/
https://ncbi.nlm.nih.gov/pubmed/24243165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-013-0261-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak